Genentech Acquires the OriGene TrueClone™ Collection
News Mar 30, 2006
OriGene cDNA clones are expression-ready, authentic full-length cDNA plasmids for use in target and lead identification and validation.
The cDNAs are designed to allow scientists to easily query the roles of genes in disease phenotypes and pathways.
"OriGene's mission is to build the most comprehensive collection of human full-length cDNAs in expression-ready vectors and to make this collection available to all researchers for systematic studies of human gene functions," said Karl Kovacs PhD, Vice President of Alliance Management at OriGene.
"We are glad to see our clones involved in the highly innovative research at Genentech."
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE